{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:39:28Z","timestamp":1786549168645,"version":"build-2736575974"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.2215\/cjn.04670510","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T23:51:02Z","timestamp":1282866662000},"page":"1893-1903","source":"Crossref","is-referenced-by-count":54,"title":["The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis"],"prefix":"10.2215","volume":"5","author":[{"given":"Robert F.","family":"Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo J.","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary V.","family":"Desir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20230601","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1751-7176.2008.00009.x","article-title":"All thiazide-like diuretics are not chlorthalidone: Putting the ACCOMPLISH study into perspective","volume":"11","author":"Ernst","year":"2009","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R4-26-20230601","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365515909060464","article-title":"Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine","volume":"11","author":"Lamberg","year":"1959","journal-title":"Scand J Clin Lab Invest"},{"key":"R5-26-20230601","first-page":"2350","article-title":"L'effect hypocalciurique des sulfamides diuretiques","volume":"37","author":"Lichwitz","year":"1959","journal-title":"Sem Hop Paris"},{"key":"R6-26-20230601","first-page":"614","article-title":"The use of thiazides in the prevention of renal calculi","volume":"102","author":"Yendt","year":"1970","journal-title":"CMAJ"},{"key":"R7-26-20230601","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0022-5347(17)51711-5","article-title":"The stone clinic effect in patients with idiopathic calcium urolithiasis","volume":"130","author":"Hosking","year":"1983","journal-title":"J Urol"},{"key":"R8-26-20230601","first-page":"916","article-title":"Regression to the mean: A potential source of error in clinical pharmacological studies","volume":"19","author":"Spector","year":"1985","journal-title":"Drug Intell Clin Pharm"},{"key":"R9-26-20230601","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00005344-199312050-00014","article-title":"Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences","volume":"22","author":"Borghi","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R10-26-20230601","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-5347(17)42599-7","article-title":"Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not","volume":"139","author":"Ettinger","year":"1988","journal-title":"J Urol"},{"key":"R11-26-20230601","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0210-4806(06)73444-1","article-title":"Papel de las tiazidas en la profilaxis de la litiasis calcica recidivante","volume":"30","author":"Fernandez-Rodriguez","year":"2006","journal-title":"Actas Urol Esp"},{"key":"R12-26-20230601","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0954-6820.1984.tb05023.x","article-title":"Thiazide prophylaxis of urolithiasis. A double-blind study in general practice","volume":"215","author":"Laerum","year":"1984","journal-title":"Acta Med Scand"},{"key":"R13-26-20230601","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02082712","article-title":"Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones","volume":"18","author":"Mortensen","year":"1986","journal-title":"Int Urol Nephrol"},{"key":"R14-26-20230601","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.1992.tb15624.x","article-title":"Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria","volume":"69","author":"Ohkawa","year":"1992","journal-title":"Br J Urol"},{"key":"R16-26-20230601","first-page":"39","article-title":"Comparison of medical treatment for the prevention of recurrent calcium nephrolithiasis","volume":"12","author":"Wilson","year":"1984","journal-title":"Urol Res"},{"key":"R17-26-20230601","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(81)90302-0","article-title":"Do thiazides prevent recurrent idiopathic renal calcium stones?","volume":"2","author":"Brocks","year":"1981","journal-title":"Lancet"},{"key":"R18-26-20230601","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-5347(17)53269-3","article-title":"Double-blind study with thiazide in recurrent calcium lithiasis","volume":"128","author":"Scholz","year":"1982","journal-title":"J Urol"},{"key":"R19-26-20230601","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1046\/j.1523-1755.2001.00746.x","article-title":"Twenty-four-hour urine chemistries and the risk of kidney stones among women and men","volume":"59","author":"Curhan","year":"2001","journal-title":"Kidney Int"},{"key":"R20-26-20230601","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1464-410X.1996.00633.x","article-title":"Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria","volume":"78","author":"Martins","year":"1996","journal-title":"Br J Urol"},{"key":"R21-26-20230601","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1973.tb19454.x","article-title":"The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism","volume":"194","author":"Jorgensen","year":"1973","journal-title":"Acta Med Scand"},{"key":"R22-26-20230601","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt1973142209","article-title":"Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite","volume":"14","author":"Pak","year":"1973","journal-title":"Clin Pharmacol Ther"},{"key":"R23-26-20230601","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-5347(17)43526-9","article-title":"The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment","volume":"138","author":"Pena","year":"1987","journal-title":"J Urol"},{"key":"R24-26-20230601","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.1978.58","article-title":"Prevention of calcium stones with thiazides","volume":"13","author":"Yendt","year":"1978","journal-title":"Kidney Int"},{"key":"R25-26-20230601","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-5347(17)50438-3","article-title":"Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis","volume":"131","author":"Nicar","year":"1984","journal-title":"J Urol"},{"key":"R26-26-20230601","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"key":"R27-26-20230601","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R30-26-20230601","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(80)90438-6","article-title":"Treatment of mild hypertension: A five year controlled drug trial. The Oslo study","volume":"69","author":"Helgeland","year":"1980","journal-title":"Am J Med"},{"key":"R34-26-20230601","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","article-title":"Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial","volume":"1","author":"Amery","year":"1985","journal-title":"Lancet"},{"key":"R37-26-20230601","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"R38-26-20230601","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"R39-26-20230601","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","article-title":"Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study","volume":"259","author":"Wikstrand","year":"1988","journal-title":"JAMA"},{"key":"R40-26-20230601","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004872-198710000-00009","article-title":"Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial","volume":"5","author":"Wilhelmsen","year":"1987","journal-title":"J Hypertens"},{"key":"R41-26-20230601","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"R42-26-20230601","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"R43-26-20230601","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group","volume":"270","author":"Neaton","year":"1993","journal-title":"JAMA"},{"key":"R44-26-20230601","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"R45-26-20230601","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"R46-26-20230601","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/00004872-199816110-00014","article-title":"The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness","volume":"16","author":"Zanchetti","year":"1998","journal-title":"J Hypertens"},{"key":"R47-26-20230601","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med"},{"key":"R48-26-20230601","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"R49-26-20230601","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"R50-26-20230601","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"R51-26-20230601","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"R52-26-20230601","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"R53-26-20230601","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archinte.160.2.211","article-title":"Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group","volume":"160","author":"Wang","year":"2000","journal-title":"Arch Intern Med"},{"key":"R54-26-20230601","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00004872-199610000-00013","article-title":"Shanghai trial of nifedipine in the elderly (STONE)","volume":"14","author":"Gong","year":"1996","journal-title":"J Hypertens"},{"key":"R55-26-20230601","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"R57-26-20230601","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"R58-26-20230601","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"R59-26-20230601","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CRD.0b013e3181c61b52","article-title":"Hydrochlorothiazide versus chlorthalidone in the management of hypertension","volume":"18","author":"Neff","year":"2010","journal-title":"Cardiol Rev"},{"key":"R60-26-20230601","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","article-title":"Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability","volume":"43","author":"Carter","year":"2004","journal-title":"Hypertension"},{"key":"R62-26-20230601","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1751-7176.2008.00029.x","article-title":"Using diuretics in practice\u2014One opinion","volume":"10","author":"Elliott","year":"2008","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R63-26-20230601","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"key":"R64-26-20230601","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra0907219","article-title":"Use of diuretics in patients with hypertension","volume":"361","author":"Ernst","year":"2009","journal-title":"N Engl J Med"},{"key":"R65-26-20230601","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/000331977602701210","article-title":"A double-blind study of chlorthalidone and hydrochlorothiazide in an outpatient population of moderate hypertensives","volume":"27","author":"Finnerty","year":"1976","journal-title":"Angiology"},{"key":"R66-26-20230601","first-page":"532","article-title":"Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension","volume":"92","author":"Radevski","year":"2002","journal-title":"S Afr Med J"},{"key":"R67-26-20230601","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"key":"R68-26-20230601","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ajh.2010.1","article-title":"Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium","volume":"23","author":"Ernst","year":"2010","journal-title":"Am J Hypertens"},{"key":"R69-26-20230601","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1185\/03007998309109837","article-title":"Indapamide in the treatment of essential arterial hypertension: Results of a controlled study","volume":"8","author":"Plante","year":"1983","journal-title":"Curr Med Res Opin"},{"key":"R70-26-20230601","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)","volume":"18","author":"Franse","year":"2000","journal-title":"J Hypertens"},{"key":"R71-26-20230601","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1524-6175.2006.04587.x","article-title":"Is the development of diabetes with antihypertensive therapy a problem?\u2014Pro","volume":"8","author":"Verdecchia","year":"2006","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R72-26-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9629(15)40676-7","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","journal-title":"Am J Med Sci"},{"key":"R73-26-20230601","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0002-8703(00)90325-9","article-title":"Diuretics and beta-blockers: is there a risk for dyslipidemia?","volume":"139","author":"Weir","year":"2000","journal-title":"Am Heart J"},{"key":"R74-26-20230601","first-page":"32","article-title":"Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: A direct comparison","volume":"7","author":"Spence","year":"2000","journal-title":"Can J Clin Pharmacol"},{"key":"R75-26-20230601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.292.1.43-c","article-title":"Meta-analysis of health outcomes of chlorthalidone-based versus nonchlorthalidone-based low-dose diuretic therapies","volume":"292","author":"Psaty","year":"2004","journal-title":"JAMA"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201010000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:10Z","timestamp":1786369210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201010000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04670510","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}